Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion type Assertion NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_head.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion description "[A heterotopic xenograft model in athymic mice using HT29 and LoVo human colon cancer cells was used to evaluate the effect of the 5-LOX inhibitor zileuton on tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_provenance.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion evidence source_evidence_literature NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_provenance.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion SIO_000772 18927292 NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_provenance.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion wasDerivedFrom befree-20150227 NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_provenance.
- NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_assertion wasGeneratedBy ECO_0000203 NP236279.RAFph_bWqr68DCtclp2-2mdA2YmZdL3X3_22Y8jQYIjP4130_provenance.